Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Casopitant is a neurokinin-1 (NK1) receptor antagonist (Ki = 0.33 nM).1 It is selective for the NK1 receptor over a panel of 70 G protein-coupled receptors (GPCRs), ion channels, and transporters at 10 µM. Casopitant inhibits substance P-induced increases in intracellular calcium in CHO cells expressing the human NK1 receptor (pA2 = 9.7). Oral administration of casopitant (1 mg/kg) increases social interaction time in the social exploration test in gerbils, indicating anxiolytic-like activity. It inhibits GR73632-induced foot tapping in gerbils with half-maximal inhibitory dose (ID50) values of 0.08, 0.04, 0.19, and 1.1 mg/kg when administered 1, 4, 8, or 24 hours prior to GR73632, respectively.
WARNING This product is not for human or veterinary use.
1. Discovery and biological characterization of (2R,4S)-